树突状细胞的提取与肿瘤免疫治疗之间的关系  

The Relationship between the Extraction of Dendritic Cells and the Immunotherapy of Tumor

作　　者：薛洋[1] 师建国[1] 

机构地区：[1]第四军医大学基础病理与病理生理学教研室,陕西西安710032

出　　处：《黑龙江医学》2012年第1期23-26,共4页Heilongjiang Medical Journal

摘　　要：人类树突状细胞(DC)是连接先天性免疫反应和获得性免疫反应的桥梁。做为一种抗原提呈细胞(APC),DC可以提呈肿瘤抗原并激活抗肿瘤的免疫反应。许多的研究和临床试验都证实了DC在肿瘤治疗上面的巨大潜能。不断提高对DC的认识,有助于改进和提高其临床应用的方法。Dendritic cells form the connection between innate and adoptive mechanisms of the immune system.As antigen-presenting cells,dendritic cells are capable of presenting tumour antigen and effectively stimulating immune response targeted against tumour.A number of preclinical and clinical studies document dendritic cells′ potential in anti-cancer treatment.Increasing knowledge of dendritic cell biology is leading to improved methods for their preparation for clinical application.

关 键 词：综述 树突状细胞(DC) 肿瘤疫苗 促熟细胞因子 

分 类 号：R730.57[医药卫生—肿瘤]